Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Davidson

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
ACR Open Rheumatology|June 1, 2021
Renal Mononuclear Phagocytes in Lupus NephritisAnne Davidson
Current Opinion in Immunology|October 26, 2010
Targeting BAFF in autoimmunityAnne Davidson
Arthritis & Rheumatology (Hoboken, N.J.)|September 25, 2014
Editorial: autoimmunity to vimentin and lupus nephritisAnne Davidson
Nature Reviews. Rheumatology|November 20, 2015
What is damaging the kidney in lupus nephritis?Anne Davidson
Nature Clinical Practice. Rheumatology|November 30, 2006
New immune modulatory drugs for systemic lupus erythematosus--what can we expect?Anne Davidson
Current Rheumatology Reports|April 27, 2012
The rationale for BAFF inhibition in systemic lupus erythematosusAnne Davidson
Journal of Perioperative Practice|May 29, 2015
Standard UK autologous transfusion labelAnne Davidson,
Trends in Immunology|July 15, 2011
BAFF and selection of autoreactive B cellsZheng Liu, Anne Davidson
Expert Reviews in Molecular Medicine|January 22, 2008
Targeting of the immune system in systemic lupus erythematosusMeera Ramanujam, Anne Davidson
Arthritis Research & Therapy|September 24, 2004
The current status of targeting BAFF/BLyS for autoimmune diseasesMeera Ramanujam, Anne Davidson
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
ACR Open Rheumatology|June 1, 2021
Renal Mononuclear Phagocytes in Lupus NephritisAnne Davidson
Current Opinion in Immunology|October 26, 2010
Targeting BAFF in autoimmunityAnne Davidson
Arthritis & Rheumatology (Hoboken, N.J.)|September 25, 2014
Editorial: autoimmunity to vimentin and lupus nephritisAnne Davidson
Nature Reviews. Rheumatology|November 20, 2015
What is damaging the kidney in lupus nephritis?Anne Davidson
Nature Clinical Practice. Rheumatology|November 30, 2006
New immune modulatory drugs for systemic lupus erythematosus--what can we expect?Anne Davidson
Current Rheumatology Reports|April 27, 2012
The rationale for BAFF inhibition in systemic lupus erythematosusAnne Davidson
Journal of Perioperative Practice|May 29, 2015
Standard UK autologous transfusion labelAnne Davidson,
Trends in Immunology|July 15, 2011
BAFF and selection of autoreactive B cellsZheng Liu, Anne Davidson
Expert Reviews in Molecular Medicine|January 22, 2008
Targeting of the immune system in systemic lupus erythematosusMeera Ramanujam, Anne Davidson
Arthritis Research & Therapy|September 24, 2004
The current status of targeting BAFF/BLyS for autoimmune diseasesMeera Ramanujam, Anne Davidson
Pageof 15